Pragati Medi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-06-2024
- Paid Up Capital ₹ 0.13 M
as on 30-06-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -87.54%
(FY 2019)
- Profit -83.78%
(FY 2019)
- Ebitda -84.94%
(FY 2019)
- Net Worth 0.03%
(FY 2019)
- Total Assets -0.05%
(FY 2019)
About Pragati Medi Pharma
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Najrul Molla, Nabin Jha, Laltu Ghosh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232WB2011PTC165176
- Company No.
165176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pragati Medi Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Najrul Molla  | Director | 22-Jul-2011 | Current |
| Nabin Jha | Director | 29-Jun-2013 | Current |
| Laltu Ghosh | Director | 22-Jul-2011 | Current |
| Subrata Paul | Director | 22-Jul-2011 | Current |
Financial Performance and Corporate Structure Insights of Pragati Medi Pharma.
Pragati Medi Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 87.54% decrease. The company also saw a substantial fall in profitability, with a 83.78% decrease in profit. The company's net worth moved up by a moderate rise of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pragati Medi Pharma?
In 2019, Pragati Medi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kolkata-Delhi Truck Terminus LimitedActive 20 years 4 daysNajrul Molla and Laltu Ghosh are mutual person
- Pragati Procon Private LimitedActive 15 years 4 months
Najrul Molla, Nabin Jha and 1 more are mutual person
- Dankuni Warehousing Private LimitedActive 11 years 11 months
Najrul Molla, Nabin Jha and 1 more are mutual person
- Maharaja Dealtrade Private LimitedActive 13 years 6 months
Najrul Molla, Nabin Jha and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pragati Medi Pharma?
Unlock and access historical data on people associated with Pragati Medi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pragati Medi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pragati Medi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
